BPEA Private Equity Rebrands as Brooke Private Equity
New name reflects the firm's heritage and continued focus on small buyout and growth investing
Originally established as Brooke Private Equity Associates and subsequently known as BPEA Private Equity, the Firm is adopting Brooke Private Equity as a simpler expression of its history and identity today.
"The Brooke name has been part of our story from the beginning," said
The Brooke name reflects the legacy of co-founder,
Brooke invests in small and lower middle market businesses through a combination of fund and direct investments alongside sector-focused private equity managers and independent sponsors. Its investment programs span three distinct strategies: diversified small buyout and growth, dedicated healthcare investing, and independent sponsor investing.
"Our history is an important part of who we are, and the relationships we have built continue to shape how we invest," said
About Brooke Private Equity
Founded in 2002, Brooke Private Equity is a Boston-based private equity firm focused on small and lower middle market buyout and growth investments. The Firm invests in private equity funds and directly in companies through small buyout and growth, healthcare-focused, and independent sponsor investment programs. Brooke combines an established network of manager and sponsor relationships with investment experience across business services and software, healthcare, consumer and retail, and industrial businesses.
For more information, visit www.brookepe.com.
Contact
Tim Maul
Director of Investor Relations
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/bpea-private-equity-rebrands-as-brooke-private-equity-302918337.html
SOURCE Brooke Private Equity
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Riboscience Presents Phase 1a/b Overall Survival Data for ENPP1 Inhibitor RBS2418 as Monotherapy and in Combination Therapy in Advanced Solid Tumors and Late-Line CRC
- EBSCO Clinical Decisions Appoints Paul Tuten as Executive Vice President
- Bluerock Names Keith Lampi CEO of Bluerock Tax Solutions, Expanding Firm's Tax-Advantaged Platform for the Private Wealth Market
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
TA AssociatesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share